ABVX
Price
$9.95
Change
-$0.39 (-3.77%)
Updated
Jul 18 closing price
Capitalization
641.75M
22 days until earnings call
MLTX
Price
$54.18
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Capitalization
3.37B
19 days until earnings call
Interact to see
Advertisement

ABVX vs MLTX

Header iconABVX vs MLTX Comparison
Open Charts ABVX vs MLTXBanner chart's image
Abivax SA
Price$9.95
Change-$0.39 (-3.77%)
Volume$620K
Capitalization641.75M
MoonLake Immunotherapeutics
Price$54.18
Change-$0.00 (-0.00%)
Volume$14
Capitalization3.37B
ABVX vs MLTX Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. MLTX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and MLTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 20, 2025
Stock price -- (ABVX: $9.95 vs. MLTX: $54.18)
Brand notoriety: ABVX and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 159% vs. MLTX: 0%
Market capitalization -- ABVX: $641.75M vs. MLTX: $3.37B
ABVX [@Biotechnology] is valued at $641.75M. MLTX’s [@Biotechnology] market capitalization is $3.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • ABVX’s TA Score: 5 bullish, 4 bearish.
  • MLTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABVX is a better buy in the short-term than MLTX.

Price Growth

ABVX (@Biotechnology) experienced а +20.31% price change this week, while MLTX (@Biotechnology) price change was +10.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ABVX is expected to report earnings on Aug 11, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.37B) has a higher market cap than ABVX($642M). ABVX YTD gains are higher at: 35.929 vs. MLTX (0.055). MLTX (-168.14M) and ABVX (-170.04M) have comparable annual earnings (EBITDA) . MLTX has more cash in the bank: 480M vs. ABVX (104M). MLTX has less debt than ABVX: MLTX (75.6M) vs ABVX (92.6M). ABVX (0) and MLTX (0) have equivalent revenues.
ABVXMLTXABVX / MLTX
Capitalization642M3.37B19%
EBITDA-170.04M-168.14M101%
Gain YTD35.9290.05564,854%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M480M22%
Total Debt92.6M75.6M122%
TECHNICAL ANALYSIS
Technical Analysis
ABVXMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 12 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STITX7.660.01
+0.13%
Virtus SGA International Growth I
NEIAX56.13N/A
N/A
Columbia Large Cap Index A
WWSYX20.63N/A
N/A
Westwood Quality SmallCap Fund Ultra
JSVTX15.64-0.04
-0.26%
Janus Henderson Small-Mid Cap Value T
VGHAX71.55-0.61
-0.85%
Vanguard Health Care Adm

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with SYRE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
-3.77%
SYRE - ABVX
40%
Loosely correlated
-3.55%
MLTX - ABVX
39%
Loosely correlated
N/A
XENE - ABVX
38%
Loosely correlated
N/A
CGON - ABVX
37%
Loosely correlated
N/A
DYN - ABVX
37%
Loosely correlated
-4.04%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with IDYA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
N/A
IDYA - MLTX
46%
Loosely correlated
-2.26%
XNCR - MLTX
46%
Loosely correlated
-1.10%
XENE - MLTX
45%
Loosely correlated
N/A
CLDX - MLTX
44%
Loosely correlated
-2.44%
CRNX - MLTX
44%
Loosely correlated
-5.78%
More